ID   CDKL5_HUMAN             Reviewed;        1030 AA.
AC   O76039-1;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 2.
DT   12-OCT-2022, entry version 210.
DE   RecName: Full=Isoform 2 of Cyclin-dependent kinase-like 5 {ECO:0000305};
DE            EC=2.7.11.22;
DE   AltName: Full=Serine/threonine-protein kinase 9;
GN   Name=CDKL5 {ECO:0000312|HGNC:HGNC:11411}; Synonyms=STK9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9721213; DOI=10.1006/geno.1998.5391;
RA   Montini E., Andolfi G., Caruso A., Buchner G., Walpole S.M., Mariani M.,
RA   Consalez G.G., Trump D., Ballabio A., Franco B.;
RT   "Identification and characterization of a novel serine-threonine kinase
RT   gene from the Xp22 region.";
RL   Genomics 51:427-433(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INVOLVEMENT IN DEE2, CHROMOSOMAL
RP   TRANSLOCATION, AND VARIANT PRO-791.
RX   PubMed=12736870; DOI=10.1086/375538;
RA   Kalscheuer V.M., Tao J., Donnelly A., Hollway G., Schwinger E., Kuebart S.,
RA   Menzel C., Hoeltzenbein M., Tommerup N., Eyre H., Harbord M., Haan E.,
RA   Sutherland G.R., Ropers H.-H., Gecz J.;
RT   "Disruption of the serine/threonine kinase 9 gene causes severe X-linked
RT   infantile spasms and mental retardation.";
RL   Am. J. Hum. Genet. 72:1401-1411(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21748340; DOI=10.1007/s00439-011-1058-x;
RA   Williamson S.L., Giudici L., Kilstrup-Nielsen C., Gold W., Pelka G.J.,
RA   Tam P.P., Grimm A., Prodi D., Landsberger N., Christodoulou J.;
RT   "A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an
RT   alternative C-terminus and is the predominant transcript in brain.";
RL   Hum. Genet. 131:187-200(2012).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 339-789.
RX   PubMed=8864140; DOI=10.1002/jlb.60.4.540;
RA   Krause S.W., Rehli M., Kreutz M., Schwarzfischer L., Paulauskis J.D.,
RA   Andreesen J.D.;
RT   "Differential screening leads to novel genetic markers of monocyte to
RT   macrophage maturation.";
RL   J. Leukoc. Biol. 60:540-545(1996).
RN   [6]
RP   INVOLVEMENT IN DEE2.
RX   PubMed=15492925; DOI=10.1086/426462;
RA   Weaving L.S., Christodoulou J., Williamson S.L., Friend K.L.,
RA   McKenzie O.L.D., Archer H., Evans J., Clarke A., Pelka G.J., Tam P.P.L.,
RA   Watson C., Lahooti H., Ellaway C.J., Bennetts B., Leonard H., Gecz J.;
RT   "Mutations of CDKL5 cause a severe neurodevelopmental disorder with
RT   infantile spasms and mental retardation.";
RL   Am. J. Hum. Genet. 75:1079-1093(2004).
RN   [7]
RP   INTERACTION WITH MECP2, FUNCTION, AUTOPHOSPHORYLATION, AND INVOLVEMENT IN
RP   DEE2.
RX   PubMed=15917271; DOI=10.1093/hmg/ddi198;
RA   Mari F., Azimonti S., Bertani I., Bolognese F., Colombo E., Caselli R.,
RA   Scala E., Longo I., Grosso S., Pescucci C., Ariani F., Hayek G.,
RA   Balestri P., Bergo A., Badaracco G., Zappella M., Broccoli V., Renieri A.,
RA   Kilstrup-Nielsen C., Landsberger N.;
RT   "CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible
RT   for the early-onset seizure variant of Rett syndrome.";
RL   Hum. Mol. Genet. 14:1935-1946(2005).
RN   [8]
RP   FUNCTION, AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, AND CHARACTERIZATION
RP   OF VARIANTS DEE2 PHE-152 AND SER-175.
RX   PubMed=16935860; DOI=10.1074/jbc.m606325200;
RA   Bertani I., Rusconi L., Bolognese F., Forlani G., Conca B., De Monte L.,
RA   Badaracco G., Landsberger N., Kilstrup-Nielsen C.;
RT   "Functional consequences of mutations in CDKL5, an X-linked gene involved
RT   in infantile spasms and mental retardation.";
RL   J. Biol. Chem. 281:32048-32056(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-761, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-720, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-479 AND SER-720, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0007744|PDB:4BGQ}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-303 IN COMPLEX WITH SYNTHETIC
RP   INHIBITOR, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=29420175; DOI=10.1016/j.celrep.2017.12.083;
RA   Canning P., Park K., Goncalves J., Li C., Howard C.J., Sharpe T.D.,
RA   Holt L.J., Pelletier L., Bullock A.N., Leroux M.R.;
RT   "CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary
RT   Function.";
RL   Cell Rep. 22:885-894(2018).
RN   [15]
RP   VARIANTS DEE2 PHE-152 AND SER-175, AND VARIANT PRO-791.
RX   PubMed=15499549; DOI=10.1086/426460;
RA   Tao J., Van Esch H., Hagedorn-Greiwe M., Hoffmann K., Moser B., Raynaud M.,
RA   Sperner J., Fryns J.-P., Schwinger E., Gecz J., Ropers H.-H.,
RA   Kalscheuer V.M.;
RT   "Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene
RT   are associated with severe neurodevelopmental retardation.";
RL   Am. J. Hum. Genet. 75:1149-1154(2004).
RN   [16]
RP   INVOLVEMENT IN DEE2.
RX   PubMed=15689447; DOI=10.1136/jmg.2004.026237;
RA   Scala E., Ariani F., Mari F., Caselli R., Pescucci C., Longo I., Meloni I.,
RA   Giachino D., Bruttini M., Hayek G., Zappella M., Renieri A.;
RT   "CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms.";
RL   J. Med. Genet. 42:103-107(2005).
RN   [17]
RP   VARIANT DEE2 ASN-72, AND VARIANT CYS-444.
RX   PubMed=16015284; DOI=10.1038/sj.ejhg.5201451;
RA   Evans J.C., Archer H.L., Colley J.P., Ravn K., Nielsen J.B., Kerr A.,
RA   Williams E., Christodoulou J., Gecz J., Jardine P.E., Wright M.J.,
RA   Pilz D.T., Lazarou L., Cooper D.N., Sampson J.R., Butler R., Whatley S.D.,
RA   Clarke A.J.;
RT   "Early onset seizures and Rett-like features associated with mutations in
RT   CDKL5.";
RL   Eur. J. Hum. Genet. 13:1113-1120(2005).
RN   [18]
RP   VARIANTS DEE2 LEU-180 AND ALA-793.
RX   PubMed=16611748; DOI=10.1136/jmg.2006.041467;
RA   Archer H.L., Evans J., Edwards S., Colley J., Newbury-Ecob R.,
RA   O'Callaghan F., Huyton M., O'Regan M., Tolmie J., Sampson J., Clarke A.,
RA   Osborne J.;
RT   "CDKL5 mutations cause infantile spasms, early onset seizures, and severe
RT   mental retardation in female patients.";
RL   J. Med. Genet. 43:729-734(2006).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-368.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-374; GLN-574; ALA-734; PRO-791 AND
RP   GLY-1023 (ISOFORM 2).
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [21]
RP   VARIANTS DEE2 VAL-40; PRO-220 AND MET-718.
RX   PubMed=18790821; DOI=10.1093/brain/awn197;
RA   Bahi-Buisson N., Nectoux J., Rosas-Vargas H., Milh M., Boddaert N.,
RA   Girard B., Cances C., Ville D., Afenjar A., Rio M., Heron D.,
RA   N'guyen Morel M.A., Arzimanoglou A., Philippe C., Jonveaux P., Chelly J.,
RA   Bienvenu T.;
RT   "Key clinical features to identify girls with CDKL5 mutations.";
RL   Brain 131:2647-2661(2008).
RN   [22]
RP   VARIANTS DEE2 VAL-40 AND PRO-220, AND CHARACTERIZATION OF VARIANTS DEE2
RP   VAL-40 AND PRO-220.
RX   PubMed=17993579; DOI=10.1136/jmg.2007.053504;
RA   Rosas-Vargas H., Bahi-Buisson N., Philippe C., Nectoux J., Girard B.,
RA   N'Guyen Morel M.A., Gitiaux C., Lazaro L., Odent S., Jonveaux P.,
RA   Chelly J., Bienvenu T.;
RT   "Impairment of CDKL5 nuclear localisation as a cause for severe infantile
RT   encephalopathy.";
RL   J. Med. Genet. 45:172-178(2008).
RN   [23]
RP   VARIANTS DEE2 PRO-178; ILE-288 AND TYR-291.
RX   PubMed=18809835; DOI=10.1212/01.wnl.0000326592.37105.88;
RA   Elia M., Falco M., Ferri R., Spalletta A., Bottitta M., Calabrese G.,
RA   Carotenuto M., Musumeci S.A., Lo Giudice M., Fichera M.;
RT   "CDKL5 mutations in boys with severe encephalopathy and early-onset
RT   intractable epilepsy.";
RL   Neurology 71:997-999(2008).
RN   [24]
RP   VARIANT DEE2 THR-399.
RX   PubMed=19253388; DOI=10.1002/ajmg.a.32711;
RA   Sprovieri T., Conforti F.L., Fiumara A., Mazzei R., Ungaro C., Citrigno L.,
RA   Muglia M., Arena A., Quattrone A.;
RT   "A novel mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5)
RT   gene associated with a severe Rett phenotype.";
RL   Am. J. Med. Genet. A 149:722-725(2009).
RN   [25]
RP   VARIANTS DEE2 THR-72 AND ARG-127, AND VARIANTS PRO-791 AND CYS-923 (ISOFORM
RP   2).
RX   PubMed=19241098; DOI=10.1007/s10048-009-0177-1;
RA   Russo S., Marchi M., Cogliati F., Bonati M.T., Pintaudi M., Veneselli E.,
RA   Saletti V., Balestrini M., Ben-Zeev B., Larizza L.;
RT   "Novel mutations in the CDKL5 gene, predicted effects and associated
RT   phenotypes.";
RL   Neurogenetics 10:241-250(2009).
RN   [26]
RP   VARIANT DEE2 GLN-178.
RX   PubMed=23662938; DOI=10.1111/epi.12203;
RA   Kodera H., Kato M., Nord A.S., Walsh T., Lee M., Yamanaka G., Tohyama J.,
RA   Nakamura K., Nakagawa E., Ikeda T., Ben-Zeev B., Lev D., Lerman-Sagie T.,
RA   Straussberg R., Tanabe S., Ueda K., Amamoto M., Ohta S., Nonoda Y.,
RA   Nishiyama K., Tsurusaki Y., Nakashima M., Miyake N., Hayasaka K.,
RA   King M.C., Matsumoto N., Saitsu H.;
RT   "Targeted capture and sequencing for detection of mutations causing early
RT   onset epileptic encephalopathy.";
RL   Epilepsia 54:1262-1269(2013).
RN   [27]
RP   VARIANTS DEE2 TYR-145; GLN-178; PRO-182; GLU-207; TYR-581 AND CYS-858, AND
RP   VARIANT 855-SER--LYS-960 DEL.
RX   PubMed=23708187; DOI=10.1038/ng.2646;
RA   Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J., Cook J.,
RA   Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S., Wallace G.,
RA   Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S., Mackay M.T.,
RA   Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z., Zelnick N.,
RA   Lerman-Sagie T., Lev D., Moeller R.S., Gill D., Andrade D.M., Freeman J.L.,
RA   Sadleir L.G., Shendure J., Berkovic S.F., Scheffer I.E., Mefford H.C.;
RT   "Targeted resequencing in epileptic encephalopathies identifies de novo
RT   mutations in CHD2 and SYNGAP1.";
RL   Nat. Genet. 45:825-830(2013).
RN   [28]
RP   VARIANT DEE2 GLN-178.
RX   PubMed=24564546; DOI=10.1186/1471-2350-15-24;
RA   Zhao Y., Zhang X., Bao X., Zhang Q., Zhang J., Cao G., Zhang J., Li J.,
RA   Wei L., Pan H., Wu X.;
RT   "Clinical features and gene mutational spectrum of CDKL5-related diseases
RT   in a cohort of Chinese patients.";
RL   BMC Med. Genet. 15:24-24(2014).
RN   [29]
RP   VARIANT LEU-647.
RX   PubMed=25969726; DOI=10.1186/s13229-015-0017-0;
RA   Codina-Sola M., Rodriguez-Santiago B., Homs A., Santoyo J., Rigau M.,
RA   Aznar-Lain G., Del Campo M., Gener B., Gabau E., Botella M.P.,
RA   Gutierrez-Arumi A., Antinolo G., Perez-Jurado L.A., Cusco I.;
RT   "Integrated analysis of whole-exome sequencing and transcriptome profiling
RT   in males with autism spectrum disorders.";
RL   Mol. Autism 6:21-21(2015).
RN   [30]
RP   VARIANTS DEE2 TRP-178; MET-718 AND 726-SER--LYS-1030 DEL.
RX   PubMed=26993267; DOI=10.1136/jmedgenet-2015-103263;
RA   Trump N., McTague A., Brittain H., Papandreou A., Meyer E., Ngoh A.,
RA   Palmer R., Morrogh D., Boustred C., Hurst J.A., Jenkins L., Kurian M.A.,
RA   Scott R.H.;
RT   "Improving diagnosis and broadening the phenotypes in early-onset seizure
RT   and severe developmental delay disorders through gene panel analysis.";
RL   J. Med. Genet. 53:310-317(2016).
RN   [31]
RP   VARIANTS DEE2 LEU-196 AND ARG-994 (ISOFORM 2).
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D., Bigoni S.,
RA   Barba C., Mari F., Montomoli M., Pisano T., Rosati A., Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O76039-2; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O76039-1; Sequence=VSP_060755;
CC   -!- TISSUE SPECIFICITY: Predominant transcript in brain.
CC       {ECO:0000269|PubMed:21748340}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS14186.1; -.
DR   RefSeq; NP_001032420.1; NM_001037343.1.
DR   RefSeq; NP_003150.1; NM_003159.2.
DR   ProteomicsDB; 50359; -.
DR   Ensembl; ENST00000379989.6; ENSP00000369325.3; ENSG00000008086.13.
DR   Ensembl; ENST00000379996.7; ENSP00000369332.3; ENSG00000008086.13.
DR   Proteomes; UP000005640; Chromosome X.
PE   1: Evidence at protein level;
FT   VARIANT         923
FT                   /note="R -> C (in dbSNP:rs267608664)"
FT                   /evidence="ECO:0000269|PubMed:19241098"
FT                   /id="VAR_083796"
FT   VARIANT         994
FT                   /note="G -> R (in DEE2; unknown pathological significance;
FT                   dbSNP:rs866859766)"
FT                   /evidence="ECO:0000269|PubMed:27864847"
FT                   /id="VAR_083797"
FT   VARIANT         999
FT                   /note="V -> M (in dbSNP:rs35693326)"
FT                   /id="VAR_083798"
FT   VARIANT         1023
FT                   /note="E -> G (in dbSNP:rs34166184)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_083799"
SQ   SEQUENCE   1030 AA;  115538 MW;  8A1C9C438610EF08 CRC64;
     MKIPNIGNVM NKFEILGVVG EGAYGVVLKC RHKETHEIVA IKKFKDSEEN EEVKETTLRE
     LKMLRTLKQE NIVELKEAFR RRGKLYLVFE YVEKNMLELL EEMPNGVPPE KVKSYIYQLI
     KAIHWCHKND IVHRDIKPEN LLISHNDVLK LCDFGFARNL SEGNNANYTE YVATRWYRSP
     ELLLGAPYGK SVDMWSVGCI LGELSDGQPL FPGESEIDQL FTIQKVLGPL PSEQMKLFYS
     NPRFHGLRFP AVNHPQSLER RYLGILNSVL LDLMKNLLKL DPADRYLTEQ CLNHPTFQTQ
     RLLDRSPSRS AKRKPYHVES STLSNRNQAG KSTALQSHHR SNSKDIQNLS VGLPRADEGL
     PANESFLNGN LAGASLSPLH TKTYQASSQP GSTSKDLTNN NIPHLLSPKE AKSKTEFDFN
     IDPKPSEGPG TKYLKSNSRS QQNRHSFMES SQSKAGTLQP NEKQSRHSYI DTIPQSSRSP
     SYRTKAKSHG ALSDSKSVSN LSEARAQIAE PSTSRYFPSS CLDLNSPTSP TPTRHSDTRT
     LLSPSGRNNR NEGTLDSRRT TTRHSKTMEE LKLPEHMDSS HSHSLSAPHE SFSYGLGYTS
     PFSSQQRPHR HSMYVTRDKV RAKGLDGSLS IGQGMAARAN SLQLLSPQPG EQLPPEMTVA
     RSSVKETSRE GTSSFHTRQK SEGGVYHDPH SDDGTAPKEN RHLYNDPVPR RVGSFYRVPS
     PRPDNSFHEN NVSTRVSSLP SESSSGTNHS KRQPAFDPWK SPENISHSEQ LKEKEKQGFF
     RSMKKKKKKS QTVPNSDSPD LLTLQKSIHS ASTPSSRPKE WRPEKISDLQ TQSQPLKSLR
     KLLHLSSASN HPASSDPRFQ PLTAQQTKNS FSEIRIHPLS QASGGSSNIR QEPAPKGRPA
     LQLPDGGCDG RRQRHHSGPQ DRRFMLRTTE QQGEYFCCGD PKKPHTPCVP NRALHRPISS
     PAPYPVLQVR GTSMCPTLQV RGTDAFSCPT QQSGFSFFVR HVMREALIHR AQVNQAALLT
     YHENAALTGK
//
